Navigation Links
Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
Date:8/21/2008

neys, leading to inflammation, the formation of disfiguring nodules (tophi), intermittent attacks of severe pain (acute flares), and kidney damage (nephropathy). While gout is a treatable condition, there are limited treatment options and a number of adverse effects are associated with current therapies. No new therapies have been approved by the FDA for the treatment of hyperuricemia associated with gout in the past 40 years

About RDEA594

RDEA594, our lead product candidate for the treatment of gout, is a major metabolite of RDEA806, our lead non-nucleoside reverse transcriptase inhibitor (NNRTI) in clinical development for the treatment of HIV. RDEA594 does not have antiviral activity and is believed to be responsible for the uric acid-lowering effects observed following administration of RDEA806 to over 100 subjects in Phase 1 and Phase 2 clinical trials. In Phase 1 studies of RDEA806 in normal healthy volunteers, increased urinary excretion of uric acid was observed in the first 24 hours after dosing, with statistically significant, exposure-dependent, decreases in serum uric acid of 35% to 50% observed during multiple dosing out to 14 days.

About RDEA806

RDEA806 is a novel NNRTI for the potential treatment of HIV infection. Based on preclinical and clinical studies to date, we believe that RDEA806 may have important competitive advantages compared to currently available NNRTIs. These include the potential for potent antiviral activity against a wide range of HIV viral isolates, including those that are resistant to efavirenz (Sustiva(R)) and other currently available NNRTIs; a high genetic barrier to resistance; limited pharmacokinetic interactions with other drugs; no reproductive toxicity based on animal studies; and the potential to be readily co-formulated in a single pill with other HIV antiviral drugs, such as Truvada(R) (emtricitabine and tenofovir) from Gilead Sciences, Inc, which is important for patient compliance.

A
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... WASHINGTON and NEW YORK ... 2014 As the leading distributor of market ... a new research report by IQ4I Research and Consultancy ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast ...
(Date:11/26/2014)...  At the American Dental Association,s Annual Meeting in ... Kerr Group was honored to be part of the ... to see and test the Best of Class winners ... on the latest developments in dental technology. This year, ... CariVu Caries Detection Device and Kerr Demi ™  ...
(Date:11/26/2014)... , Nov. 25, 2014 Reinforcing its ... Philips (NYSE: PHG AEX: PHIA) ... Drug Administration (FDA) for its IQon Spectral CT ... This first-of-its kind technology adds a new dimension to ... the ability to characterize structures based on their material ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3
... ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today ... will present at the 10th Annual BIOInvestor Forum Conference on ... the Sea Cliff Salon at the Palace Hotel in San ... audio webcast and slide presentation on the ADVENTRX Pharmaceuticals web ...
... YORK, Oct. 19, 2011 Reportlinker.com announces that ... its catalogue: Flow Cytometry: Products, ... http://www.reportlinker.com/p0568366/Flow-Cytometry-Products-Technologies-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic REPORT HIGHLIGHTS ... * An overview of the flow cytometry ...
Cached Medicine Technology:Flow Cytometry: Products, Technologies and Global Markets 2Flow Cytometry: Products, Technologies and Global Markets 3Flow Cytometry: Products, Technologies and Global Markets 4Flow Cytometry: Products, Technologies and Global Markets 5Flow Cytometry: Products, Technologies and Global Markets 6Flow Cytometry: Products, Technologies and Global Markets 7Flow Cytometry: Products, Technologies and Global Markets 8Flow Cytometry: Products, Technologies and Global Markets 9Flow Cytometry: Products, Technologies and Global Markets 10Flow Cytometry: Products, Technologies and Global Markets 11Flow Cytometry: Products, Technologies and Global Markets 12
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... Salvage ( http://www.rustysautosalvage.com ), one of the nation's leading ... junk and salvage vehicles to be more competitive and ... customer’s lives during this festive time of year. , ... many car owners across the US also deal with ...
(Date:11/28/2014)... Novatus, a leading provider of contract ... provides customers with greater reporting capabilities, more searchable ... we continue to evolve and grow the Novatus ... improved performance in response to requests from our ... the enhancements that we have made to Advanced ...
(Date:11/28/2014)... November 28, 2014 Dr. Andrew Campbell, ... , announced the expansion of Quintessa Aesthetic Center into ... be located at W307 N1497 Golf Road in Suite ... to Dr. Campbell, the new Delafield location will offer ... for patients, including: Botox, filler injectables , micro ...
(Date:11/28/2014)... 28, 2014 Dr. Paul Vitenas, one of the ... Glitter & Glow Holiday Event for those in the area that ... his practice. Glitter & Glow will take place on December 11, ... location in the heart of Houston at 4208 Richmond Ave. ... hope that you will come and celebrate the season with us ...
(Date:11/28/2014)... 2014 Written and narrated by award winning ... releases the “The Happiest Man In the World: Life ... of how and why Project C.U.R.E. came to be. , ... Josie and the Reverend Richard W. Jackson, Dr. Jackson exceeded ... 30, but realized that he wasn’t happy. Prompted by this ...
Breaking Medicine News(10 mins):Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 2Health News:Cosmetic Surgeon Dr. Paul Vitenas to Host Glitter & Glow Holiday Event 3Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2
... Doctor ... Information and Reviews, NEW YORK, Jan. 28 ... relations firms, today announced the addition of,Vitals.com to its client roster. ... free, online doctor evaluation,service., Vitals.com provides consumers with access -- ...
... Dr. Cheryl Healton, President and CEO, WASHINGTON, ... New York State Department of Health for taking ... Administration (FDA) to,allow over-the-counter sales of nicotine replacement ... sold. This petition attempts to move,forward easier access ...
... Purposes Granted to Global Vaccines, FT. ... 28, InkSure Technologies Inc. (OTC Bulletin Board:,INKS), ... solutions,("CMRT") for the detection of counterfeiting, fraud ... of innovative authentication,and item-level identification technologies, today ...
... Disease Claims as Many Lives Each Year as Breast ... For the second,year in a row, pulmonary fibrosis ... Union address. Just a year ago, Caesar Borja, Jr.,attended ... after his,father lost his fight to live as he ...
... YORK, Jan. 28 Nanotech Briefs has announced a ... competition, which,launched on January 7. The Nano 50 recognizes ... potential to advance the,commercialization of nanotechnology., Nominations are ... at,the official awards Web site: http://www.nanotechbriefs.com/nano50 . The ...
... short strands of RNA that can interfere with ... how closely they are associated with cancer. In a ... colleagues have identified two microRNAs (miRNAs) that promote tumors ... provide an early warning of metastatic breast cancer and ...
Cached Medicine News:Health News:MWW Group Selected by First-Ever Online Doctor Evaluation Service Vitals.com 2Health News:American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications 2Health News:InkSure and AuthentiForm Announce Assignment of Patent Portfolio 2Health News:InkSure and AuthentiForm Announce Assignment of Patent Portfolio 3Health News:Pulmonary Fibrosis Patients/9/11 Responders Represented at State of the Union Address for Second Year in a Row 2Health News:Nanotech Briefs Announces Call for Nominations for the Fourth Annual Nano 50(TM) Awards 2Health News:2 microRNAs promote spread of tumor cells 2Health News:2 microRNAs promote spread of tumor cells 3
The Sonic WAVE™is the first market-ready Alternative to Ultrasound...
... compact Sleepscan Traveler provides the ultimate flexibility ... PSG data in the home, a patient ... sleep studies utilize the same powerful Sleepscan ... Sleepscan Traveler studies take full advantage of ...
... sampling EEG with 64 channel display capability. ... as well as epilepsy centers, sleep labs ... for automatic spike and seizure detection, and ... Data Acquisition ,The Neurofax EEG-1100 is available ...
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: